CELL INTELLIGENCE · 肿瘤细胞治疗研究

通过嵌合抗原受体协调肿瘤抗原摄取与树突状细胞活化

Coordinate tumor-antigen uptake and dendritic cell activation by chimeric antigen receptors.

与黑色素瘤共培养后 GD2 特异性小鼠 CAR-T 细胞代谢的变化

Changes in the Metabolism of GD2-Specific Murine CAR-T Cells After Co-Culturing with Melanoma.

CAR-T 细胞治疗与外周实体瘤重建性肿瘤外科手术：叙述性综述

CAR-T cell therapy and reconstructive oncologic surgery in peripheral solid tumors-A narrative review.

血液学之外——嵌合抗原受体（CAR）T 细胞治疗皮肤与结缔组织疾病的最新认识

Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders.

无病毒 CRISPR 将嵌合抗原受体敲入 KLRC1 产生强效 GD2 特异性 NK 细胞

Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells.

GD2 特异性 CAR-T 细胞在 GD2 阳性转移性黑色素瘤和其他实体癌患者中的 1 期试验的安全性和生物学结果

Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid

这是第三代 GD2 靶向 CAR-T 细胞在转移性黑色素瘤及其他实体癌（如结直肠癌）患者中的首次报告，显示了可行性、安全性和免疫活性，但临床效果有限。

细胞因子武装的树突状细胞祖细胞用于抗原非依赖性肿瘤免疫治疗

Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy.

CAR-T 细胞疗法治疗黑色素瘤：I 期临床试验系统综述

Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Melanoma: A Systematic Review of Phase One Clinical Trials.

使用锆-89 标记的 APOMAB®检测体内免疫介导的肿瘤细胞死亡

Detection of immune-mediated tumour cell death in vivo using Zirconium-89-labeled APOMAB®.

从人类多能干细胞生成抗 GD2 CAR 巨噬细胞用于癌症免疫治疗

Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies.